Skip to content

Serratus anterior plane block with bupivacaine liposome for children with pectus excavatum after Nuss procedure: A randomized controlled trial

Serratus anterior plane block with bupivacaine liposome for children with pectus excavatum after Nuss procedure: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115374
Enrollment
Unknown
Registered
2025-12-25
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after NUSS surgery for pectus excavatum

Interventions

Control group (Ropivacaine):Performing pre-serratus plane block with ropivacaine
Experimental group (bupivacaine liposome):Performing pre-serratus plane block with bupivacaine liposome

Sponsors

Guangzhou Medical University Affiliated Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age greater than 12 years old; 2. ASA classification I-II level; 3. This is the first time for the patient to undergo the NUSS surgery for pectus excavatum; 4. No cognitive impairment, no mental disorders.

Exclusion criteria

Exclusion criteria: 1. Does not meet the inclusion criteria; 2. Pectus excavatum correction surgery combined with other surgeries; 3. Allergic to bupivacaine liposome; 4. Infection, trauma at the puncture site, abnormal coagulation function.

Design outcomes

Primary

MeasureTime frame
NRS pain scores;

Secondary

MeasureTime frame
The child's first use of rescue analgesia, and the first time they got up and out of bed;Statistics on the total use of various analgesics in pediatric patients, the number of times patient-controlled analgesia was used, family satisfaction scores with pain management, length of hospital stay, and hospitalization costs;

Countries

China

Contacts

Public ContactXu Yingyi

Guangzhou Medical University Affiliated Women and Children's Medical Center

513438980@qq.com+86 136 3232 4394

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026